The Life Sciences Data Challenge
Life sciences organizations are generating unprecedented volumes of multimodal data, clinical, omics, imaging, sensor, real-world data, and more. Yet much of this data remains fragmented across systems, under-utilized, and difficult to convert into decision-grade insight.
At the same time, the pressure to bring therapies to market faster, design smarter trials, and personalize treatment is intensifying. Meeting these demands requires not one-off projects, but durable AI assets that can be validated, productized, and deployed across multiple programs and partners.
A company built around AI assets, Not projects
InnovaAi is structured as an AI asset development company. We design, train, and validate domain-specific AI models and data assets that can be licensed, integrated, and scaled across life sciences use cases.
Rather than delivering bespoke consulting engagements, we invest in building repeatable, regulatory-grade assets that capture institutional knowledge, encode life sciences domain expertise, and continuously improve as new data is generated.
How we Build and Scale AI Assets
Our platform will span the full AI asset lifecycle, from raw data ingestion through to validated, deployable models:
Data ingestion & Harmonization
We unify structured and unstructured data from clinical systems, EDC, registries, biobanks, sensors, and imaging into analysis-ready formats.
Feature Engineering & Representation Learning
We encode complex biological, clinical, and operational signals into robust feature spaces tailored to specific life sciences problems.
Model Development & Validation
We develop AI models, including deep learning, classical ML, and hybrid symbolic approaches, and validate them against clinically meaningful outcomes and endpoints.
Deployment-Ready Assets
The output will be a portfolio of AI assets (models, data structures, knowledge graphs, and workflows) that can be integrated into partner environments via APIs, SDKs, or embedded applications.
Our Focus Areas
Jensen Huang
“AI will be the most transformative technology of the 21st century. It will affect every industry and aspect of our lives” – Jensen Huang CEO at NVIDIA, 2021
AI asset Modules in our Platform
Data Ingestion & Feature Extraction Engine
Data Mining, Extraction and Analysis
Our ingestion engine will connect to EDC, EHR, lab systems, registries, and external datasets, harmonizing and de-identifying data while preserving clinical and biological signal. Built-in feature extraction pipelines convert raw data into model-ready representations for each therapeutic and functional domain.
Outcome & Response Prediction Models
Predictive Modelling
We’ll develop predictive models that estimate clinical outcomes, treatment response, and operational performance based on thousands of variables. These models are trained on real-world and clinical trial data and designed to support decisions such as trial design, patient stratification, and risk-based monitoring.
Clinical & Safety Risk Engine
Risk Management
Our risk engine will quantify patient, site, and protocol-level risk using streaming and batch data. It will be integrated into clinical operations and pharmacovigilance workflows to prioritize interventions and support proactive risk mitigation.
Portfolio & Business Analytics Models
Business Analytics
We will maintain analytics models focused on portfolio valuation, indication sequencing, and commercial scenario analysis. These models will transform complex scientific and market inputs into decision-ready views for R&D and business leaders.
Scenario Simulation & Foresight Models
Reactive & Prospective Analytics
Our simulation assets will enable “what-if” exploration of protocol changes, eligibility criteria, enrollment strategies, and market dynamics, helping teams anticipate downstream impact before committing resources.
Deployment Connectors & Integration Layer
System Integration Services
InnovaAi assets will be delivered through a set of integration connectors and APIs that plug into existing clinical, safety, and data platforms. This layer is productized and maintained by InnovaAi, minimizing partner implementation burden.
Machine Learning & Deep Learning Model Library
Machine Learning
Our platform will incorporate a curated library of ML and deep learning architectures optimized for life sciences data types, including time-series, images, genomics, and multimodal combinations. Models can be re-used and fine-tuned across programs, accelerating asset development.
Hybrid & Cognitive AI Stack
Deep Learning
Beyond pure statistical models, we will encode domain knowledge using ontologies, rules, and knowledge graphs. This hybrid approach increases interpretability, supports regulatory discussions, and aligns model behavior with established medical and scientific understanding.
Data Foundation & Governance Layer
Application & Solution Architecture
A robust data foundation underpins each AI asset, including lineage, provenance, quality metrics, and governance controls. This enables traceability and auditability aligned with life sciences regulatory expectations.
Process & Workflow Encapsulation
Classic & Cognitive AI
Our assets will capture and codify domain-specific workflows, from protocol design to signal detection, so that best practices become repeatable software capabilities, not ad-hoc processes.
Scalable Compute & Distributed Architecture
Comprehensive Data Strategy
InnovaAi’s platform will be built on distributed architectures that support large-scale training and inference, ensuring that models can be applied to high-volume, high-dimensional life sciences datasets without compromising performance.
AI Asset Incubation & Pipeline Management
Domain-Specific Process Transformation
New AI assets are continuously incubated within our platform, from early prototypes to validated, partner-ready offerings. We prioritize use cases based on clinical impact, regulatory feasibility, and economic value, maintaining a clear asset pipeline for investors and partners.
Our Team
Our team brings together experts in AI, software engineering, and data infrastructure with seasoned professionals from Biopharma, Medical Devices, and Healthcare Delivery.
Collectively, we have experience across:
Drug Discovery and Translational Research
Clinical Trial Design and Operations
Regulatory and Quality in Life Sciences
Health Economics and Real-World Evidence
This combination of technical and domain expertise enables InnovaAi to build AI assets that are scientifically rigorous, operationally realistic, and aligned with how life sciences organizations actually work.
Contact Us
Partner or invest with InnovaAi
Get in touch to explore: